Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
The treatment of patients at risk of developing Wernicke s encephalopathy in the community Thomson AD; Marshall EJAlcohol Alcohol 2006[Mar]; 41 (2): 159-67AIM: To review the process of identifying alcohol-dependent patients at risk of developing Wernicke's encephalopathy (WE) in the community, and prophylactic treatment options. METHODS: Non-systematic literature review of the diagnosis of thiamine deficiency and of its treatment in the community. The role of supplementation of beer and bread with thiamine was evaluated. RESULTS: The diagnosis of thiamine deficiency is not always made, and treatment apparently may sometimes be inadequate. CONCLUSIONS: Alcohol-dependent patients in the community who are at risk of developing WE should be given thiamine 250 mg, intramuscularly, daily for 3-5 days as part of a community detoxification programme. Further work is essential to determine the optimum dose of thiamine required to prevent permanent brain damage (Korsakoff's Psychosis). Neurotoxicity, due to the metabolism of excessive alcohol in patients with chronic and severe alcohol dependence, must be considered as an important factor in determining the long-term outcome of treatment.|Beer[MESH]|Bread[MESH]|Community Mental Health Services/*organization & administration[MESH]|Dietary Supplements[MESH]|Humans[MESH]|Mass Screening/*methods[MESH]|Risk Factors[MESH]|Thiamine Deficiency/drug therapy/epidemiology[MESH]|Thiamine/administration & dosage/*therapeutic use[MESH]|Vitamin B 12 Deficiency/drug therapy/epidemiology[MESH]|Vitamin B 12/therapeutic use[MESH]|Wernicke Encephalopathy/*drug therapy/*epidemiology/prevention & control[MESH] |
